These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 37977547

  • 1. Development of a Hypercoagulable-Hypofibrinolytic State Early After Spinal Cord Injury.
    Park AJ, Garcia VP, Greiner JJ, Berry AR, Cardenas HL, Wegerson KN, Stauffer B, DeSouza CA.
    Arch Phys Med Rehabil; 2024 May; 105(5):843-849. PubMed ID: 37977547
    [Abstract] [Full Text] [Related]

  • 2. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
    DeSouza CA, Jones PP, Seals DR.
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
    [Abstract] [Full Text] [Related]

  • 3. Global REACH 2018: Influence of excessive erythrocytosis on coagulation and fibrinolytic factors in Andean highlanders.
    DeSouza NM, Brewster LM, Bain AR, Garcia VP, Stone R, Stockelman KA, Greiner JJ, Tymko MM, Vizcardo-Galindo G, Figueroa-Mujica RJ, Villafuerte FC, Ainslie PN, DeSouza CA.
    Exp Physiol; 2021 Jun; 106(6):1335-1342. PubMed ID: 33745204
    [Abstract] [Full Text] [Related]

  • 4. Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia.
    Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM.
    Br J Haematol; 2002 Dec; 119(4):1011-6. PubMed ID: 12472582
    [Abstract] [Full Text] [Related]

  • 5. Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.
    Bulava A, Slavík L, Fiala M, Heinc P, Skvarilova M, Lukl J, Krcová V, Indrák K.
    J Interv Card Electrophysiol; 2004 Jun; 10(3):271-9. PubMed ID: 15133367
    [Abstract] [Full Text] [Related]

  • 6. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
    Erem C, Nuhoglu I, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO.
    Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
    [Abstract] [Full Text] [Related]

  • 7. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U.
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [Abstract] [Full Text] [Related]

  • 8. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 9. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
    Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C, Iannaccone L, Khamashta MA, Hughes GR, Brancaccio V.
    Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 11. Increased plasma fibrinolytic activity in bleeding gastrointestinal angiodysplasia.
    Junquera F, Saperas E, Anglés A, Abadía C, Monasterio J, Malagelada JR.
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):199-205. PubMed ID: 15674098
    [Abstract] [Full Text] [Related]

  • 12. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
    Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H.
    J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
    [Abstract] [Full Text] [Related]

  • 13. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.
    van de Kar NC, van Hinsbergh VW, Brommer EJ, Monnens LA.
    Pediatr Res; 1994 Aug; 36(2):257-64. PubMed ID: 7970942
    [Abstract] [Full Text] [Related]

  • 14. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
    Eriksson-Berg M, Egberg N, Eksborg S, Schenck-Gustafsson K.
    Thromb Res; 2002 Mar 15; 105(6):481-6. PubMed ID: 12091046
    [Abstract] [Full Text] [Related]

  • 15. [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus].
    Liu BY, Jian YL, Zhong M, Yu YH, Wang Q, Zhang J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan 15; 27(1):35-7. PubMed ID: 17259140
    [Abstract] [Full Text] [Related]

  • 16. Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock.
    Skagius E, Siegbahn A, Bergqvist D, Henriksson AE.
    J Thromb Haemost; 2008 Jan 15; 6(1):147-50. PubMed ID: 17922806
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolytic and protease inhibitory systems in spinal cord injured patients with end-stage renal disease.
    Vaziri ND, Winer RL, Gonzales EV, Eltorai IM.
    J Am Paraplegia Soc; 1993 Jul 15; 16(3):149-52. PubMed ID: 7690062
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
    Warshofsky MK, Wasserman HS, Wang W, Teng P, Sciacca R, Apfelbaum M, Schwartz A, Michler RE, Mancini DM, Cannon PJ, Rabbani LE.
    Am J Cardiol; 1997 Jul 15; 80(2):145-9. PubMed ID: 9230149
    [Abstract] [Full Text] [Related]

  • 19. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
    Jia XQ, Dong CM, Qin J, Zhang L.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr 15; 24(4):225-8. PubMed ID: 22464576
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolytic and inflammatory processes in pleural effusions.
    Philip-Joët F, Alessi MC, Philip-Joët C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I.
    Eur Respir J; 1995 Aug 15; 8(8):1352-6. PubMed ID: 7489803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.